about
A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicityOver-expression of alpha-synuclein in human neural progenitors leads to specific changes in fate and differentiationPolo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivoΑlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's DiseaseControl of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1Tmc gene therapy restores auditory function in deaf mice.Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactionsAmyloid-β plaque deposition measured using propagation-based X-ray phase contrast CT imaging.Parkinson's disease-linked mutations in VPS35 induce dopaminergic neurodegeneration.alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.Loss of MITF expression during human embryonic stem cell differentiation disrupts retinal pigment epithelium development and optic vesicle cell proliferation.The adipocyte differentiation protein APMAP is an endogenous suppressor of Aβ production in the brain.Cellular implants: pioneers in xenotransplantation?SOD1 silencing in motoneurons or glia rescues neuromuscular function in ALS mice.Perineuronal net digestion with chondroitinase restores memory in mice with tau pathology.PGC-1α activity in nigral dopamine neurons determines vulnerability to α-synucleinα-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9).Using human neural stem cells to model neurological disease.Pathway-specific reorganization of projection neurons in somatosensory cortex during learning.Encapsulated cellular implants for recombinant protein delivery and therapeutic modulation of the immune system.Sustained expression of PGC-1α in the rat nigrostriatal system selectively impairs dopaminergic function.α-Synuclein increases β-amyloid secretion by promoting β-/γ-secretase processing of APP.Endoplasmic reticulum stress is important for the manifestations of α-synucleinopathy in vivo.Viral vectors, animal models and new therapies for Parkinson's disease.Measurement of autophagy flux in the nervous system in vivo.Gene Therapy: A Promising Approach for Neuroprotection in Parkinson's Disease?Large-scale chondroitin sulfate proteoglycan digestion with chondroitinase gene therapy leads to reduced pathology and modulates macrophage phenotype following spinal cord contusion injury.Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.Long-range connectivity of mouse primary somatosensory barrel cortex.Genetic engineering of cell lines using lentiviral vectors to achieve antibody secretion following encapsulated implantation.A high-capacity cell macroencapsulation system supporting the long-term survival of genetically engineered allogeneic cells.Lentiviral vectors express chondroitinase ABC in cortical projections and promote sprouting of injured corticospinal axons.A subcutaneous cellular implant for passive immunization against amyloid-β reduces brain amyloid and tau pathologies.Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy.In Vivo Evidence for a Lactate Gradient from Astrocytes to Neurons.Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates.Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease.Axonal Localization of Integrins in the CNS Is Neuronal Type and Age DependentA self-immunomodulating myoblast cell line for erythropoietin delivery.Regulation of Memory Formation by the Transcription Factor XBP1.
P50
Q24296968-A9DFE1BC-FFF1-4143-999E-EA51B03E8C85Q24297619-5410FA17-6E12-445B-9B28-C0CC3FFDDE0FQ24320103-D1123AE8-9295-4A48-ABFD-042BB32CABC5Q26778937-9942776C-42C7-4171-84A7-6FBD71D98357Q28509073-D1A812C1-3A67-4031-809D-A8C6F17672ACQ30279047-8EA7020F-6893-4B0D-A492-F4AEC833C8E2Q30496792-352CE400-0C40-4D5D-918C-6D496B2E11EEQ30839078-54EB5D6E-B204-47E7-BA7D-A83F6AFBEB69Q33991769-05BC1B4E-91DC-4D14-AB85-9CCB26658365Q34076094-C6D75505-33B6-434B-9540-D86A089748E5Q34463231-6E1B28BF-3C2C-4DE6-ADD1-BC0E81057AE0Q34764030-C4275345-C43E-4C5F-94FA-D1862365FCE2Q35067196-2F62B54D-6FB9-44D1-9848-F2EC27CE29C6Q35115920-5355F710-D275-4A22-8195-23FDE6F8BBABQ35159349-8AA245C4-8CFE-438A-B175-857D89A7FEEDQ35233106-694F8900-18C4-49FF-A83D-8AA3A9D52718Q35475433-1609AEBD-432A-49A0-B275-8702FF260057Q35634536-FDCBB927-DE96-43BC-9F24-0B93EB15B600Q35670665-A38ED26E-8E87-4BF5-B24B-CF28F50F1B81Q35723422-60EC00BE-2223-4830-BC1C-34E4ECDA35EBQ35856269-4A24CE85-7816-4C19-822F-F2DF1C22328CQ36277049-63182F86-36E1-4E79-A0B6-1B58C6DE60E9Q36289970-AE6BFD47-8C0B-40FD-A265-13E473C616A7Q37202132-A15FEE62-FD5B-42C7-BAFB-FD9BE38827E9Q37357038-B7D17484-3B1D-4B28-81D3-BBA22B930264Q37516424-B02CC0BF-F3F7-40F2-829D-F96507FAA543Q37679296-321A77E5-6511-4737-8D70-8BE72DE4A367Q37713838-640DD43D-5385-495A-B3AA-892F91E69C59Q37765313-BA7023AB-859C-401D-8FA9-E95E2243D21CQ39042677-368BE982-1879-4EB4-BD75-6A776EAA5D20Q39084567-958FC3C2-54C3-4473-9A39-BF6830525D97Q39727641-9C7664B7-0AB0-4815-814F-A3A962EFEDDCQ39937890-15EDFD1B-735C-4981-8315-E784F9FE6E50Q40151605-650ACAD5-2BAB-4E3C-A040-59213F27455EQ40177119-72A864AB-D2FF-47EE-9B38-5D03D030757FQ40339968-664BCB90-A030-43C5-8638-5C7EC4BEF129Q40348917-6A65DBD4-7140-4BD5-AA59-A8244478025FQ40603663-72990298-B1EE-4EB0-BAD6-F8A4FBF36D75Q40799718-AEEED6A4-7F3D-49E0-A5ED-9D506D41B611Q40801142-6EA0A7ED-8ED8-40FE-BD0F-91A412A6F35D
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Bernard L Schneider
@nl
Bernard L Schneider
@sl
Bernard L. Schneider
@en
Bernard L. Schneider
@es
type
label
Bernard L Schneider
@nl
Bernard L Schneider
@sl
Bernard L. Schneider
@en
Bernard L. Schneider
@es
altLabel
Bernard L Schneider
@en
Bernard Schneider
@en
prefLabel
Bernard L Schneider
@nl
Bernard L Schneider
@sl
Bernard L. Schneider
@en
Bernard L. Schneider
@es
P1053
H-6168-2011
P106
P1153
7402402024
P21
P31
P3829
P4012
P496
0000-0001-5485-8748